MetLife Investment Management’s Lifeway Foods LWAY Stock Holding History

MetLife Investment Management’s Portfolio LWAY Stock Details LWAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,061	Closed	-$85K	–	2849
2025 Q3	$85K	Buy	+3,061	New	+$86.1K	﹤0.01%	2717

Other funds holding LWAY

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

CAM

Cresset Asset Management Chicago, Illinois $23.1B AUM 27.04% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Slotnik Capital Dallas, Texas $342M AUM 105.92% 1-Year Est. Return

MetLife Investment Management's LWAY Position: Q4 2025 in Review

MetLife Investment Management sold out of Lifeway Foods (LWAY) in Q4 2025, closing a stake of 3,061 shares — an estimated $85K sold.

MetLife Investment Management first reported a position in LWAY in Q3 2025 and held it in 1 quarter. The position peaked at $85K in Q3 2025. 89 funds tracked by Wall St. Rank hold LWAY as of Q4 2025.

MetLife Investment Management reported no remaining Lifeway Foods position as of Q4 2025 after selling out during the quarter.
MetLife Investment Management sold 3,061 Lifeway Foods shares in Q4 2025, an estimated $85K.
MetLife Investment Management first reported a position in Lifeway Foods in Q3 2025 and held it in 1 quarter.
MetLife Investment Management's Lifeway Foods position peaked at $85K in Q3 2025.
89 funds tracked by Wall St. Rank held Lifeway Foods as of Q4 2025.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.